[Edaily Starin Gim Ga Yeong Reporter] Actor Song Ji-ho is set to marry singer and actress Kim So-ri.
Song Ji-ho’s agency, Inyeon Entertainment, announced on the 6th, “Our actor Song Ji-ho will tie the knot with his fiancée, a fellow entertainer, and begin a beautiful life together as a married couple,” and released wedding photos. According to the agency, Song Ji-ho’s fiancée is singer and actress Kim So-ri, and the couple is getting married after a long-term relationship built on mutual trust. The wedding photos, released ahead of the wedding, feature the beautiful bride-to-be Kim So-ri, showcasing her striking features and elegant wedding dress, alongside a happy Song Ji-ho. Born in 1992, Song Ji-ho made his debut in the 2013 film *Friends 2* and has since appeared in productions such as *Youth Era*, *Secret Forest*, and *Search: WWW*. He left a particularly strong impression playing Im Geum, the older brother of the female lead Im Sol (played by Kim Hye-yoon), in *Run Away with Seonjae*, and Seo Jeong-min, the son of Cha Jeong-sook (played by Uhm Jung-hwa) and Seo In-ho (played by Kim Byung-chul), in *Doctor Cha Jeong-sook*. In the KBS2 drama *My Beloved Thief*, which wrapped up last February, he played Hong Dae-il, the older brother of Hong Eun-jo (played by Nam Ji-hyun). Born in 1990, Kim So-ri debuted as a singer in 2016 and has been active in various media projects, including her work with the group Real Girl Project (R.G.P), the variety show “Somebody 2,” the drama “Idolmaster.KR – Dreaming of Dreams,” and the survival show “Mix Nine.” In the Korean-Indian co-production *Made in Korea*, a Netflix film released last March, she played “Han Sol,” the lead vocalist of a band in the film.
As the Japanese government moves forward with plans to incorporate crypto assets into the framework of the Financial Instruments and Exchange Act (hereinafter referred to as the FIEA), the government …
curacle co., ltd.(365270)is moving forward with a U.S. Phase 2b clinical trial to develop an oral treatment for diabetic macular edema (DME). The trial will re-evaluate the treatment’s efficacy in pat…
#Aimed Bio Inc.’s antibody-drug conjugate (ADC) “BHV-1530 (AMB302),” which was licensed to U.S.-based Biohaven, has demonstrated initial anticancer efficacy in a Phase 1 clinical trial. Biohaven plans…